1. AB0481 Demonstrated, quantifiable benefits in patient reported outcomes supporting a "treat to target" paradigm for infliximab-treated RA patients previously inadequately responsive to prior anti-TNF treatment. (23rd January 2014) Authors: Ingham, M.; Tang, L.; Decktor, D.; Bolce, R.; Wang, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0310 The effect of dactylitis and enthesitis on disease burden in patients with psoriatic arthritis in the corrona registry. (23rd January 2014) Authors: Mease, P.; Saunders, K.; Bolge, S.; Bolce, R.; Decktor, D.; Reed, G.; Greenberg, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0181 Antibodies to Etanercept and Adalimumab in Rheumatoid Arthritis Inadequate Responders and Clinical Outcomes after an Active Switch to Infliximab. (23rd January 2014) Authors: Pool, C.; Shankar, G.; Schantz, A.; Gunn, G.; Bolce, R.; Leirisalo-Repo, M.; Wang, J.; Goldman, J.; DeHoratius, R.; Fleischmann, R.; Decktor, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗